Clinical Trials on Iatrogenic Ulcer After ESD
Total 12 results
-
Yonsei UniversityCompletedIatrogenic Ulcer After ESDKorea, Republic of
-
University of California, San FranciscoCompletedMarginal Ulcer | Ulcer Disease After Gastric Bypass | Perforated Marginal Ulcer | Acutely Perforated Marginal UlcerUnited States
-
University of California, San FranciscoCompletedMarginal Ulcer | Chronic Ulcer Disease | Persistent Ulcer Disease | Recurrent Ulcer Disease | Late Morbidity After Gastric BypassUnited States
-
Medical University of South CarolinaCompleted
-
Ceric SàrlEuropean Cardiovascular Research CenterRecruitingType B Aortic Dissection | Penetrating Ulcer of Aorta | Aneurysm Aortic | Residual Dissection After Type A RepairFrance
-
Maulana Azad Medical CollegeCompletedVentilator Associated Pneumonia | Etiological Organisms | Antimicrobial Drug Susceptibility Pattern | Stress Ulcer ProphylaxisIndia
-
Montefiore Medical CenterCompletedAnalgesia After ED Discharge for Extremity InjuriesUnited States
-
Chang Wei-JungCompletedPneumonia | Intraabdominal Abscess After Procedure | Leakage | Operation Wound; Infection
-
Sunnybrook Health Sciences CentreOntario Ministry of Health and Long Term Care; Sault Area Hospital; Scarborough... and other collaboratorsCompletedCatheter Related Blood Stream Infections | Ventilator Acquired Pneumonia | Pressure Ulcer Prophylaxis | DVT Prophylaxis | Restrictive Blood Transfusion Strategy | Daily Spontaeous Breathing TrialsCanada
-
Barts & The London NHS TrustCompletedEnd Stage Renal Disease | Renal Transplantation | Kidney Transplant; Complications | Metformin | New Onset Diabetes After Transplant | Post-transplant Diabetes Mellitus | New Onset Diabetes After TransplantationUnited Kingdom
-
University of California, DavisEnrolling by invitationAchalasia | Marginal Ulcer | Gastric Fistula | Stenoses | Weight Gain After Primary Weight Loss Surgery | Gastric NecUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly